This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Lobular carcinoma in situ of breast

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

LCIS commonly occurs in premenopausal women. The incidence is unknown as there are no distinctive clinical or radiologic features. The condition is usually discovered as an incidental finding when a biopsy is made for otherwise benign disease. There are no clear mammographic features. Clinically, it is not palpable and does not tend to metastasize.

LCIS is frequently bilateral and multicentric. It is associated with an eleven-fold increased risk of subsequent invasive carcinoma. There is no relation between the breast in which LCIS is detected and that in which invasive carcinoma occurs. LCIS is regarded as a marker of increased risk anywhere in the breast. Thirty percent of patients develop invasive carcinoma within 15-20 years. This is a lower relative risk than ductal carcinoma in situ.

Management consists of lifelong surveillance by annual mammography and clinical examination. As the majority of patients are premenopausal, the use of Tamoxifen may alter the hormonal milieu and diminish the risk of invasive carcinoma.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.